These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10958289)

  • 1. Abciximab in carotid stenting for postsurgical carotid restenosis: intermediate results.
    Schneiderman J; Morag B; Gerniak A; Rimon U; Varon D; Seligsohn U; Shotan A; Adar R
    J Endovasc Ther; 2000 Aug; 7(4):263-72. PubMed ID: 10958289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience.
    Qureshi AI; Suri MF; Khan J; Fessler RD; Guterman LR; Hopkins LN
    Neurosurgery; 2000 Jun; 46(6):1316-24; discussion 1324-5. PubMed ID: 10834637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid angioplasty and stent placement: a prospective analysis of perioperative complications and impact of intravenously administered abciximab.
    Qureshi AI; Suri MF; Ali Z; Kim SH; Lanzino G; Fessler RD; Ringer AJ; Guterman LR; Hopkins LN
    Neurosurgery; 2002 Mar; 50(3):466-73; discussion 473-5. PubMed ID: 11841713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting.
    Chan AW; Yadav JS; Bhatt DL; Bajzer CT; Gum PA; Roffi M; Cho L; Agah R; Topol EJ
    Am J Cardiol; 2005 Mar; 95(6):791-5. PubMed ID: 15757616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergent carotid stenting and intra-arterial abciximab in acute ischemic stroke due to tandem occlusion.
    Al-Mufti F; Amuluru K; Manning NW; Khan I; Peeling L; Gandhi CD; Prestigiacomo CJ; Pushchinska G; Fiorella D; Woo HH
    Br J Neurosurg; 2017 Oct; 31(5):573-579. PubMed ID: 28298139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracarotid abciximab injection to abort impending ischemic stroke during carotid angioplasty.
    Ho DS; Wang Y; Chui M; Wang Y; Ho SL; Cheung RT
    Cerebrovasc Dis; 2001; 11(4):300-4. PubMed ID: 11385208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting.
    Kopp CW; Steiner S; Nasel C; Seidinger D; Mlekusch I; Lang W; Bartok A; Ahmadi R; Minar E
    Stroke; 2003 Nov; 34(11):2560-7. PubMed ID: 14563968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the effect of GPIIb-IIIa antagonist in patients undergoing carotid stenting: correlation between standard aggregometry, flow cytometry and the cone and plate(let) analyzer (CPA) methods.
    Shenkman B; Schneiderman J; Tamarin I; Kotev-Emeth S; Savion N; Varon D
    Thromb Res; 2001 May; 102(4):311-7. PubMed ID: 11369424
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined carotid endarterectomy with transluminal angioplasty and primary stenting of the supra-aortic vessels.
    Arko FR; Buckley CJ; Lee SD; Manning LG; Patterson DE
    J Cardiovasc Surg (Torino); 2000 Oct; 41(5):737-42. PubMed ID: 11149641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement.
    Arab D; Yahia AM; Qureshi AI
    Int J Cardiovasc Intervent; 2003; 5(2):61-6. PubMed ID: 12745860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation.
    Bertrand OF; De Larochellière R; Rodés-Cabau J; Proulx G; Gleeton O; Nguyen CM; Déry JP; Barbeau G; Noël B; Larose E; Poirier P; Roy L;
    Circulation; 2006 Dec; 114(24):2636-43. PubMed ID: 17145988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting.
    Wholey MH; Wholey MH; Eles G; Toursakissian B; Bailey S; Jarmolowski C; Tan WA
    J Endovasc Ther; 2003 Feb; 10(1):33-41. PubMed ID: 12751927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor durability of carotid angioplasty and stenting for treatment of recurrent artery stenosis after carotid endarterectomy: an institutional experience.
    Leger AR; Neale M; Harris JP
    J Vasc Surg; 2001 May; 33(5):1008-14. PubMed ID: 11331842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial.
    Marmur JD; Mitre CA; Barnathan E; Cavusoglu E
    Am Heart J; 2006 Nov; 152(5):876-81. PubMed ID: 17070148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty.
    Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR
    Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupancy of the internal and external pools of glycoprotein IIb/IIIa following abciximab bolus and infusion.
    Quinn MJ; Murphy RT; Dooley M; Foley JB; Fitzgerald DJ
    J Pharmacol Exp Ther; 2001 May; 297(2):496-500. PubMed ID: 11303035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: a randomized trial.
    Ansel GM; Silver MJ; Botti CF; Rocha-Singh K; Bates MC; Rosenfield K; Schainfeld RM; Laster SB; Zander C
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):288-97. PubMed ID: 16408299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting balloon angioplasty to treat carotid in-stent restenosis.
    Tamberella MR; Yadav JS; Bajzer CT; Bhatt DL; Abou-Chebl A
    J Invasive Cardiol; 2004 Mar; 16(3):133-5. PubMed ID: 15152163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy.
    Kapadia SR; Bajzer CT; Ziada KM; Bhatt DL; Wazni OM; Silver MJ; Beven EG; Ouriel K; Yadav JS
    Stroke; 2001 Oct; 32(10):2328-32. PubMed ID: 11588321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.